Evidence map›Paper›PMID 41200258›Full record

ReviewCureus2025

Artificial Intelligence in Ophthalmology: Practical Applications, Subspecialty Evidence and Real-World Deployment.

Arham Yahya Rizwan Khan, Muhammad Bilal Malik

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arham Yahya Rizwan KhanMedicine and Surgery, Shifa International Hospitals Limited, Islamabad, PAK.
Muhammad Bilal MalikOphthalmology, University of Calgary, Calgary, CAN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) has undoubtedly emerged as a transformative technology in the field of medicine. In ophthalmology, it has been a catalyst for innovation in the methods used for the diagnosis, management, and treatment of different eye diseases. This article offers a detailed review of the literature on the application and utilization of AI technology in the field of ophthalmology. A detailed search of available literature on the use of AI in the field of ophthalmology was performed through the PubMed database and Google Scholar. Published literature on the role of AI in screening, diagnosis, and management of common ocular conditions such as diabetic retinopathy (DR), cataract, glaucoma, and age-related macular degeneration (AMD) was reviewed. Special emphasis was laid on the effectiveness and limitations of the recently developed AI systems for the detection and management of ocular conditions. We screened (n=4449) records and included (n=102) studies spanning retina, glaucoma, cornea, pediatric ophthalmology, neuro-ophthalmology, ocular oncology, surgery, emergencies, and tele-ophthalmology. Deep learning (DL) and machine learning (ML) algorithms have demonstrated significant performance in the analysis of ophthalmic data, including optical coherence tomography scans and retinal images, for accurately diagnosing and classifying diseases, predicting disease progression, and personalizing different treatment plans. In addition to the common ocular conditions, the use of AI has now spread to other domains of ophthalmology, such as pediatric ophthalmology, oculoplastics and reconstructive surgery, and triage and management of emergency ocular conditions. Various AI systems have shown accuracy similar to that of clinical experts, with the additional benefit of being less subjective and time-consuming. Despite significant progress, different challenges related to regulatory approval, standardization, data quality, and ethical considerations hamper the wide-scale implementation of AI in ophthalmology. Literature is evident on the transformative role of AI in screening, diagnosis, and management of various ocular conditions. However, currently, there are various challenges and limitations to the implementation of AI. Future research should focus on addressing these challenges while optimizing the utilization of AI algorithms for enhancing patient care in ophthalmology.

Indexed as

artificial intelligence (ai)artificial intelligence in healthcaredeep learning artificial intelligencemachine learningophthalmology

Identifiers

PMID41200258
PMCPMC12587209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.